Bin Gong Selected Research

Bin Gong Research Topics

Disease

16	Infections 01/2023 - 01/2012
5	Neoplasms (Cancer) 06/2023 - 01/2012
5	Spotted Fever Group Rickettsiosis (Rickettsialpox) 01/2023 - 06/2013
5	Inflammation (Inflammations) 01/2022 - 11/2012
4	Alzheimer Disease (Alzheimer's Disease) 04/2023 - 07/2017
3	Bacterial Infections (Bacterial Infection) 01/2022 - 11/2019
3	Aortic Aneurysm (Aneurysm, Aortic) 01/2008 - 01/2006
3	Hypoglycemia (Reactive Hypoglycemia) 12/2007 - 02/2005
2	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2021
2	Communicable Diseases (Infectious Diseases) 01/2020 - 01/2012
2	Vesicular Stomatitis 10/2018 - 08/2011
2	Scrub Typhus (Typhus, Scrub) 03/2016 - 09/2014
2	Rickettsia Infections 11/2013 - 01/2012
2	Hyperthermia 10/2008 - 10/2006
2	Reperfusion Injury 10/2008 - 10/2006
1	Degenerative Myopia 11/2023
1	Choroidal Neovascularization 11/2023
1	Aortitis 09/2023
1	COVID-19 09/2023
1	Dementia (Dementias) 01/2023
1	Tinnitus 01/2023
1	Macular Edema 01/2023
1	Osteoarthritis 01/2023
1	Photophobia (Light Sensitivity) 01/2023
1	Bites and Stings (Sting) 01/2023
1	Neoplasm Metastasis (Metastasis) 09/2022
1	Hepatocellular Carcinoma (Hepatoma) 09/2022
1	Adenocarcinoma of Lung 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Disease Progression 01/2022
1	Chronic Pancreatitis 01/2022
1	Ebola Hemorrhagic Fever 01/2020
1	Chondrosarcoma 01/2020

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2011
5	cadherin 5IBA 04/2023 - 01/2012
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2013
3	erythromycin propionate-N-acetylcysteinateIBA 11/2021 - 09/2020
3	carbamylhydrazine (semicarbazide)IBA 01/2008 - 01/2006
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2007 - 02/2005
3	Epinephrine (Adrenaline)FDA LinkGeneric 12/2007 - 02/2005
3	Glucose (Dextrose)FDA LinkGeneric 12/2007 - 02/2005
2	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2023
2	Therapeutic UsesIBA 01/2023 - 01/2020
2	hepatoma-derived growth factorIBA 01/2022 - 11/2021
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 11/2021
2	von Willebrand FactorIBA 11/2021 - 09/2020
2	Cyclic AMP Receptors (Cyclic AMP Receptor)IBA 11/2021 - 09/2020
2	Polymyxins (Polymyxin)IBA 11/2020 - 01/2020
2	Annexin A2 (Annexin II)IBA 01/2020 - 11/2019
2	Interleukin-10 (Interleukin 10)IBA 01/2013 - 11/2011
2	Glutathione Transferase (Glutathione S-Transferase)IBA 02/2010 - 01/2006
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2008 - 10/2006
2	Glucagon (Glukagon)FDA Link 12/2007 - 02/2005
2	Hormones (Hormone)IBA 12/2007 - 12/2007
2	EnzymesIBA 01/2006 - 01/2006
2	Amine Oxidase (Copper-Containing)IBA 01/2006 - 01/2006
1	KH902 fusion proteinIBA 11/2023
1	N-acetyltryptophanamide (NATA)IBA 11/2023
1	Viral AntigensIBA 09/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2023
1	Apolipoproteins E (ApoE)IBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	Retinaldehyde (Retinal)IBA 01/2023
1	fibroblast growth factor 21IBA 01/2023
1	afliberceptIBA 01/2023
1	CateninsIBA 09/2022
1	UbiquitinIBA 09/2022
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 01/2022
1	Urethane (Ethyl Carbamate)IBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Cyclin D1IBA 11/2021
1	Nucleosome Assembly Protein 1IBA 11/2021
1	Small Interfering RNA (siRNA)IBA 11/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2020
1	LipopeptidesIBA 11/2020
1	Adenosine Monophosphate (AMP)IBA 09/2020
1	Caspase 3 (Caspase-3)IBA 01/2020
1	Vorinostat FDA Link 01/2020
1	TalinIBA 01/2020
1	VinculinIBA 01/2020
1	PhalloidineIBA 01/2020
1	PanobinostatIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	5-ethynyl-2'-deoxyuridineIBA 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 10/2018
1	Interleukin-16 (Interleukin 16)IBA 10/2017
1	Atrial Natriuretic Factor (ANF)IBA 10/2017
1	AdiponectinIBA 10/2017
1	sortilinIBA 07/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2017
1	PPAR gammaIBA 07/2017

Therapy/Procedure

2	Aftercare (After-Treatment) 01/2023 - 11/2012
2	Therapeutics 01/2022 - 01/2020
1	Acupuncture Therapy 01/2023
1	Injections 01/2023
1	Intravitreal Injections 01/2023
1	Drug Therapy (Chemotherapy) 01/2020